CSIMarket
 
Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 

Casi Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information



CASI Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 370.7 % -2.27 % -1.7 % 5.63 %
Q / Q Revenue Growth (Q4 MRQ) - 2.16 % 1.98 % 0.88 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 42.89 % 3.46 % 4.32 % %
Seq. Revenue Growth (for 12 months ending Q4 TTM) - -1.51 % -0.36 % 1.48 %
Revenue 5 Year Average Growth 290.11 % 14.14 % 10.74 % 11.13 %


CASI's Growth Comparisons in IV. Quarter 2022




Despite the -2.27% decline in the Major Pharmaceutical Preparations industry, Casi Pharmaceuticals Inc showed impressive surge in Revenue in the forth quarter 2022 by 370.7% from the same quarter a year ago, to 43 millions, Healthcare sector decreased -1.7%. Despite modest Sales in the Healthcare sector and the Major Pharmaceutical Preparations industry, Casi Pharmaceuticals Inc reported above average market Sales growth.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by 290.11% on average in last five years, while S & P 500's including only Businesses with the forth quarter 2022 earnings reports, average yearly sales growth is 11.13%.


Growth Rates of CASI's Income in the forth quarter 2022


CASI Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 47.22 % -6.35 % -20.07 %
Seq. Operating Income Change (Q4 MRQ) - 13.02 % 16.35 % -6.72 %
Y / Y Operating Income Growth (Q4 TTM) - 4.12 % -16.34 % 3.51 %
Seq. Operating Income Growth (Q4 TTM) - -6.7 % -10.02 % -5.38 %
Operating Income 5 Year Avg. Change - 33.52 % 10.15 % 10.86 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - -24.13 % -39.27 % -21.04 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - -34.75 % -12.1 % -17.27 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - -17.53 % -40.44 % -3.14 %
Seq. Income from Cont. Ops. Change (Q4 TTM) - -19.46 % -24.39 % -5.49 %
Income from Cont. Ops. 5 Year Avg. Change - 57.24 % 23.15 % 2.84 %

CASI Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - -22.72 % -36.74 % -19.16 %
Q / Q Net Income Growth (Q4 MRQ) - -38.03 % -16.46 % -15.62 %
Y / Y Net Income Change (Q4 TTM) - -16.51 % -39.98 % -4.05 %
Seq. Net Income Change (Q4 TTM) - -19.07 % -23.94 % -5.07 %
Net Income 5 Year Avg. Growth - 57.4 % 23.18 % 3.12 %

CASI's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - 17.62 % -39.27 % -21.04 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - -29.78 % -12.1 % -17.27 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) - - - -36.1 %
EPS from Cont. Ops. 5 Year Avg. Growth - 32.23 % 23.15 % 2.84 %



CASI EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 19.8 % -36.74 % -19.16 %
Q / Q EPS Net Growth (Q4 MRQ) - -33.31 % -16.46 % -15.62 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -99.83 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) - - - -99.83 %
EPS Net 5 Year Avg. Change - 57.4 % 23.18 % 3.12 %



Casi Pharmaceuticals Inc reported bottom-line of $ -3.01 in the forth quarter, compare to $ -0.04 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 19.8%, while Healthcare sector decreased by -36.74%, and overall market declined by -19.16%.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by 290.11% on average in the last five years, while the S & P 500's including only the businesses with the forth quarter 2022 financial results, average yearly income per share growth is 3.12%.

CASI Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 11.07 % -6.55 % -2.5 %
Seq. Free Cash Flow Change (Q4 MRQ) - 6.26 % 3.98 % 26.14 %
Y / Y Free Cash Flow Change (Q4 TTM) - 1.84 % -6.16 % 0.31 %
Seq. Free Cash Flow Change (Q4 TTM) - 35.84 % 19.27 % -2.58 %
Free Cash Flow 5 Year Avg. Change - 27.42 % 18.45 % 23.3 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - - -
Seq. Net Cash Flow Change (Q4 MRQ) -57.63 % 81.42 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - -51.41 % -99.94 % -
Seq. Net Cash Flow Change (Q4 TTM) - - - -
Net Cash Flow 5 Year Avg. Change -12.5 % - 0.72 % 48.8 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 7.61 % 0.53 % -6.68 % 0.91 %
Seq. Capital Expenditures Change (Q4 MRQ) - 13.37 % 15.61 % 90.44 %
Y / Y Capital Expenditures Change (Q4 TTM) -11.68 % 7.52 % 6.33 % 0.15 %
Seq. Capital Expenditures Change (Q4 TTM) 5.29 % 12.97 % 3.36 % -1.55 %
Capital Expenditures 5 Year Avg. Change - 13.29 % 9.25 % 8.65 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com